92 related articles for article (PubMed ID: 27411269)
21. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
22. Receptor activator of NF-kappaB ligand-stimulated osteoclastogenesis in mouse marrow culture is suppressed by zinc in vitro.
Yamaguchi M; Uchiyama S
Int J Mol Med; 2004 Jul; 14(1):81-5. PubMed ID: 15202020
[TBL] [Abstract][Full Text] [Related]
23. Local bone injections of LPS and M-CSF increase bone resorption by different pathways in vivo in rats.
Orcel P; Feuga M; Bielakoff J; De Vernejoul MC
Am J Physiol; 1993 Mar; 264(3 Pt 1):E391-7. PubMed ID: 8460686
[TBL] [Abstract][Full Text] [Related]
24. Docosahexaenoic acid signaling attenuates the proliferation and differentiation of bone marrow-derived osteoclast precursors and promotes apoptosis in mature osteoclasts.
Kim HJ; Ohk B; Yoon HJ; Kang WY; Seong SJ; Kim SY; Yoon YR
Cell Signal; 2017 Jan; 29():226-232. PubMed ID: 27836739
[TBL] [Abstract][Full Text] [Related]
25. Methylsulfonylmethane Inhibits RANKL-Induced Osteoclastogenesis in BMMs by Suppressing NF-κB and STAT3 Activities.
Joung YH; Darvin P; Kang DY; Sp N; Byun HJ; Lee CH; Lee HK; Yang YM
PLoS One; 2016; 11(7):e0159891. PubMed ID: 27447722
[TBL] [Abstract][Full Text] [Related]
26. B-1 lymphocytes differentiate into functional osteoclast-like cells.
Pugliese LS; Gonçalves TO; Popi AF; Mariano M; Pesquero JB; Lopes JD
Immunobiology; 2012 Mar; 217(3):336-44. PubMed ID: 21855167
[TBL] [Abstract][Full Text] [Related]
27. Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells.
Kim JM; Lee JH; Lee GS; Noh EM; Song HK; Gu DR; Kim SC; Lee SH; Kwon KB; Lee YR
BMC Complement Altern Med; 2017 Mar; 17(1):164. PubMed ID: 28335757
[TBL] [Abstract][Full Text] [Related]
28. Pulsed electromagnetic fields stimulation affects osteoclast formation by modulation of osteoprotegerin, RANK ligand and macrophage colony-stimulating factor.
Chang K; Chang WH; Huang S; Huang S; Shih C
J Orthop Res; 2005 Nov; 23(6):1308-14. PubMed ID: 15913941
[TBL] [Abstract][Full Text] [Related]
29. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
[TBL] [Abstract][Full Text] [Related]
30. Colony stimulating factor-1 plays a role in osteoclast formation and function in bone resorption induced by parathyroid hormone and parathyroid hormone-related protein.
Weir EC; Lowik CW; Paliwal I; Insogna KL
J Bone Miner Res; 1996 Oct; 11(10):1474-81. PubMed ID: 8889847
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-7 is a direct inhibitor of in vitro osteoclastogenesis.
Lee SK; Kalinowski JF; Jastrzebski SL; Puddington L; Lorenzo JA
Endocrinology; 2003 Aug; 144(8):3524-31. PubMed ID: 12865334
[TBL] [Abstract][Full Text] [Related]
32. [Imaging observation of live cells originating from osteoclasts of the blood system].
Yu SJ; Xiao LW; Wu CL; Tong PJ
Zhongguo Gu Shang; 2012 Apr; 25(4):317-23. PubMed ID: 22812098
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory effects of triptolide on titanium particle-induced osteolysis and receptor activator of nuclear factor-κB ligand-mediated osteoclast differentiation.
Kim JA; Ihn HJ; Park JY; Lim J; Hong JM; Kim SH; Kim SY; Shin HI; Park EK
Int Orthop; 2015 Jan; 39(1):173-82. PubMed ID: 25416122
[TBL] [Abstract][Full Text] [Related]
34. [Effect of
Ren L; Xu Y; Wang H; He X; Song M; Chen X
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2017 Feb; 31(2):180-184. PubMed ID: 29786250
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of osteoclast differentiation by polycyclic aryl hydrocarbons is dependent on cell density and RANKL concentration.
Voronov I; Heersche JN; Casper RF; Tenenbaum HC; Manolson MF
Biochem Pharmacol; 2005 Jul; 70(2):300-7. PubMed ID: 15919055
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory Effects of KP-A159, a Thiazolopyridine Derivative, on Osteoclast Differentiation, Function, and Inflammatory Bone Loss via Suppression of RANKL-Induced MAP Kinase Signaling Pathway.
Ihn HJ; Lee D; Lee T; Kim SH; Shin HI; Bae YC; Hong JM; Park EK
PLoS One; 2015; 10(11):e0142201. PubMed ID: 26536233
[TBL] [Abstract][Full Text] [Related]
37. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
Chikazu D; Katagiri M; Ogasawara T; Ogata N; Shimoaka T; Takato T; Nakamura K; Kawaguchi H
J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
[TBL] [Abstract][Full Text] [Related]
38. The 1,2,3-triazole derivative KP-A021 suppresses osteoclast differentiation and function by inhibiting RANKL-mediated MEK-ERK signaling pathway.
Ihn HJ; Lee D; Lee T; Shin HI; Bae YC; Kim SH; Park EK
Exp Biol Med (Maywood); 2015 Dec; 240(12):1690-7. PubMed ID: 25769316
[TBL] [Abstract][Full Text] [Related]
39. Primary human bone marrow adipocytes support TNF-α-induced osteoclast differentiation and function through RANKL expression.
Goto H; Hozumi A; Osaki M; Fukushima T; Sakamoto K; Yonekura A; Tomita M; Furukawa K; Shindo H; Baba H
Cytokine; 2011 Dec; 56(3):662-8. PubMed ID: 21963155
[TBL] [Abstract][Full Text] [Related]
40. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
